UBS Initiates Coverage of Cameco with a Neutral Rating and a C$140.00 Price Target

MT Newswires Live
Nov 11, 2025

UBS on Monday initiated coverage of Cameco (CCO.TO, CCJ) with a neutral rating and a C$140.00

"We initiate coverage of Cameco Corp (CCO.TSX) with a Neutral rating and C$140/sh price target. Cameco offers high quality exposure to the uranium thematic, which we think looks attractive medium-long term with demand CAGR>3.5% and upside skew to uranium prices. Cameco's earnings should grow significantly this decade as it re-contracts sales at increasingly higher spot prices, while Westinghouse captures contracts on new build nuclear reactors. We think the fundamental narrative and earnings upcycle is strong, with consensus prices and earnings likely to be upgraded. However, recent headlines and positive catalysts have pushed the shares higher (+23% 3mth & +72% YTD) and it trades near full on most valuation metrics and is pricing ~$110/lb real uranium in our 1.5x NAV. We expect spot uranium prices to climb higher in 2026, with a potential inventory restocking cycle driving prices; however we remain on the sidelines given the recent momentum and trading premium," the investment bank wrote.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 131.93, Change: +2.50, Percent Change: +1.93

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10